arrow
返回

Complement system is activated in stenotic aortic valves

delete2008-01-01
delete55
PRE
AI
S
Satu Helske
R
Riina Oksjoki
K
Ken A. Lindstedt
J
Jyri Lommi
H
Heikki Turto
K
Kalervo Werkkala
M
Markku Kupari
P
Petri T. Kovanen *
DOI:10.1016/j.atherosclerosis.2007.03.040delete
delete原文链接
delete原文求助
delete分享
delete收藏
摘要

摘要

En 中文
Objective: To examine the role of the complement system, a source of powerful proinflammatory mediators, in aortic valve stenosis (AS). Methods and Results: Stenotic aortic valves (n = 24) were obtained at valve replacement surgery, and non-stenotic (n = 12) and early sclerotic (n = 4) valves at cardiac transplantations. The terminal complement complex C5b-9 was stained by immunohistochemistry. Expression of the anaphylatoxin receptors C3aR and C5aR was studied in the valves by immunohistochemistry and RT-PCR, and in isolated valve myofibroblats after stimulation with potential AS-accelerating factors (TNF-alpha and cigarette smoke) by RT-PCR. Cultured myofibroblasts were exposed to C3a, and their secretion of proinflammatory cytokines was assessed by ELISA. C5b-9 was found already in early aortic valve lesions, and its deposition was augmented in advanced stenotic valves. In stenotic valves, expression of C3aR mRNA was upregulated (p < 0.05) and strong staining of C3aR and C5aR was detected. Myofibroblasts in stenotic, but not in control valves, expressed C3aR, and, in isolated myofibroblasts, TNF-a and cigarette smoke induced C3aR mRNA expression (P < 0.05 for both). Stimulation of myofibroblasts with C3a resulted in enhanced secretion of MCP-1 (p < 0.001), IL-6 (p = 0.003), and IL-8 (p = 0.03). Conclusions: In stenotic aortic valves, complement is activated leading to generation of the anaphylatoxins C3a and C5a. Upregulation of C3aR in the valves as a result of inflammation and external risk factors, such as cigarette smoke, leads to an inflammatory response in aortic valve myofibroblasts. Complement activation in stenotic valves emerges as a novel pathogenic component of AS and may serve as a therapeutic target in this disease. (C) 2007 Elsevier Ireland Ltd. All rights reserved.
Keyword:
anaphylatoxin
aortic stenosis
complement
inflammation
valve

期刊

Atherosclerosis 封面图
Atherosclerosis
IF:
5.7
论文数:
2.0W
被引数:
2.5W

机构

U
university of helsinki
学者数:
4.1W
论文数: 3.6W
被引数: 51
W
Wihuri Research Institute
学者数:
282
论文数: 252
被引数: 534
H
helsinki university central hospital
学者数:
7.8K
论文数: 6.8K
被引数: 10
学者 查看更多机构
引用论文

引用论文

Bone formation and inflammation in cardiac valves
err2001-03-20
err930
errOAAI
errMohler, ER; Gannon, F; Reynolds, C; Zimmerman, R; Keane, MG; Kaplan, FS
err分享
err收藏
ON THE PATHOGENESIS OF ATHEROSCLEROSIS - ENZYMATIC TRANSFORMATION OF HUMAN LOW-DENSITY-LIPOPROTEIN TO AN ATHEROGENIC MOIETY
err1995-12-01
err193
errOAAI
errBHAKDI, S; DORWEILER, B; KIRCHMANN, R; TORZEWSKI, J; WEISE, E; TRANUMJENSEN, J; WALEV, I; WIELAND, E
err分享
err收藏
Complement C6 deficiency protects against diet-induced atherosclerosis in rabbits
err1998-11-01
err129
errOAAI
errSchmiedt, W; Kinscherf, R; Deigner, HP; Kamencic, H; Nauen, O; Kilo, J; Oelert, H; Metz, J; Bhakdi, S
err分享
err收藏
Tissue resident C reactive protein in degenerative aortic valves:: correlation with serum C reactive protein concentrations and modification by statins
errHEART
IF4.4
err2005-12-09
err50
errOAAI
errSkowasch, D; Schrempf, S; Preusse, CJ; Likungu, JA; Welz, A; Lüderitz, B; Bauriedel, G
err分享
err收藏
Role of complement activation in atherosclerosis
err2003-10-01
err122
PREAI
errOksjoki, R; Kovanen, PT; Pentikäinen, MO
err分享
err收藏
Thermal-sensitive Starch-g-PNIPAM prepared by Cu(0) catalyzed SET-LRP at molecular level
err2015-01-01
err0
PREAI
errLeli Wang; Ying Wu; Yongjun Men; Jianan Shen; Zhengping Liu
err分享
err收藏
学者 查看更多内容